<DOC>
	<DOCNO>NCT02608060</DOCNO>
	<brief_summary>This study examine efficacy , safety effect hemoglobin level , weekly subcutaneous injection epoetin beta ( 30,000 IU ) anemic participant non-Hodgkin 's lymphoma , chronic lymphocytic leukemia multiple myeloma . The anticipated study duration 4 month , target sample size 30 individual .</brief_summary>
	<brief_title>A Study Assess Hematopoyetic Response Anemic Patients With Hematologic Malignancies Treated With Erythropoietin B</brief_title>
	<detailed_description />
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Epoetin Alfa</mesh_term>
	<criteria>Adult participant diagnosis nonHodgkin 's lymphoma , chronic lymphocytic leukemia multiple myeloma Anemia Screening Visit Transfusion red blood cell within 2 month study drug Treatmentresistant hypertension Acute chronic bleeding ( require therapy ) within 3 month study drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>